ZWILCH expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.99299999997993E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.40869999793503E-08 |
Normal-vs-Stage2 |
5.361100E-03 |
Normal-vs-Stage3 |
3.45510000054894E-07 |
Normal-vs-Stage4 |
2.762800E-01 |
Stage1-vs-Stage2 |
2.370000E-01 |
Stage1-vs-Stage3 |
7.473200E-01 |
Stage1-vs-Stage4 |
3.885700E-02 |
Stage2-vs-Stage3 |
1.837630E-01 |
Stage2-vs-Stage4 |
3.052800E-01 |
Stage3-vs-Stage4 |
3.586100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62542999999626E-05 |
Normal-vs-AfricanAmerican |
2.037700E-04 |
Normal-vs-Asian |
5.466800E-01 |
Caucasian-vs-AfricanAmerican |
7.230200E-01 |
Caucasian-vs-Asian |
3.228200E-01 |
AfricanAmerican-vs-Asian |
2.533800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.27130000000075E-05 |
Normal-vs-Female |
3.19080000199534E-08 |
Male-vs-Female |
1.954610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.282010E-01 |
Normal-vs-Age(41-60Yrs) |
1.371800E-04 |
Normal-vs-Age(61-80Yrs) |
1.36299999953238E-07 |
Normal-vs-Age(81-100Yrs) |
5.70279999889678E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.608600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.165600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.336000E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.122000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.701300E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.140200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.736500E-03 |
Normal-vs-Grade 2 |
1.14539999707119E-08 |
Normal-vs-Grade 3 |
2.02770000790053E-09 |
Normal-vs-Grade 4 |
3.598800E-01 |
Grade 1-vs-Grade 2 |
4.938000E-01 |
Grade 1-vs-Grade 3 |
3.739400E-01 |
Grade 1-vs-Grade 4 |
3.168400E-01 |
Grade 2-vs-Grade 3 |
5.793200E-01 |
Grade 2-vs-Grade 4 |
7.608300E-02 |
Grade 3-vs-Grade 4 |
5.159900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.17070000360542E-08 |
Normal-vs-ccB subtype |
1.683800E-03 |
ccA subtype-vs-ccB subtype |
5.717300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.618230E-04 |
Normal-vs-N1 |
7.797400E-01 |
N0-vs-N1 |
5.614400E-02 |
|
|